Upregulated Histone Deacetylase 6 Associates with Malignant Progression of Melanoma and Predicts the Prognosis of Patients
Zhicheng Hu,1 Yanchao Rong,1 Shuting Li,2 Shanqiang Qu,3 Shaobin Huang4 1Burns Department, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China; 2Department of Plastic Surgery, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People&...
Main Authors: | Hu Z, Rong Y, Li S, Qu S, Huang S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/upregulated-histone-deacetylase-6-associates-with-malignant-progressio-peer-reviewed-article-CMAR |
Similar Items
-
Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines
by: Susanna Nencetti, et al.
Published: (2021-01-01) -
Histone Deacetylases as Targets for Melanoma Immunotherapy
by: Woods, David Michael
Published: (2013) -
Identification of Potential Prognostic Biomarkers Associated With Cancerometastasis in Skin Cutaneous Melanoma
by: Yang Li, et al.
Published: (2021-07-01) -
Identification of IL10RA by Weighted Correlation Network Analysis and in vitro Validation of Its Association With Prognosis of Metastatic Melanoma
by: Si Cheng, et al.
Published: (2021-01-01) -
m6A-Related lncRNAs Are Potential Biomarkers for the Prognosis of Metastatic Skin Cutaneous Melanoma
by: Suyang Huang, et al.
Published: (2021-05-01)